Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma von Gribben, John G, Fowler, Nathan, Morschhauser, Franck

Volltext

How I treat CLL up front von Gribben, John G.

Volltext

How and when I do allogeneic transplant in CLL von Gribben, John G.

Volltext

CC16 polymorphisms in asthma, asthma subtypes, and asthma control in adults from the Agricultural Lung Health Study von Gribben, K C, Wyss, A B, Poole, J A, Farazi, P A, Wichman, C, Richards-Barber, M, Beane Freeman, L E, Henneberger, P K, Umbach, D M, London, S J, LeVan, T D

Volltext

The role of B7 family molecules in hematologic malignancy von Greaves, Paul, Gribben, John G.

Volltext

Targeting the methylome to improve CLL outcome von Gribben, John G.

Volltext

Practical management of tumour lysis syndrome in venetoclax‐treated patients with chronic lymphocytic leukaemia von Gribben, John G.

Volltext

Loss of 5-hydroxymethylcytosine in cancer: Cause or consequence? von Ficz, Gabriella, Gribben, John G.

Volltext

Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma von Araf, Shamzah, Wang, Jun, Korfi, Koorosh, Pangault, Celine, Kotsiou, Eleni, Rio-Machin, Ana, Rahim, Tahrima, Heward, James, Clear, Andrew, Iqbal, Sameena, Davies, Jeff K., Johnson, Peter, Calaminici, Maria, Montoto, Silvia, Auer, Rebecca, Chelala, Claude, Gribben, John G., Graham, Trevor A., Fest, Thierry, Fitzgibbon, Jude, Okosun, Jessica

Volltext

Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study von Hillmen, Peter, Rawstron, Andy C, Brock, Kristian, Muñoz-Vicente, Samuel, Yates, Francesca J, Bishop, Rebecca, Boucher, Rebecca, MacDonald, Donald, Fegan, Christopher, McCaig, Alison, Schuh, Anna, Pettitt, Andrew, Gribben, John G, Patten, Piers E M, Devereux, Stephen, Bloor, Adrian, Fox, Christopher P, Forconi, Francesco, Munir, Talha

Volltext

To start and stop or just keep going? von Gribben, John G.

Volltext

Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations von Rejeski, Kai, Subklewe, Marion, Aljurf, Mahmoud, Bachy, Emmanuel, Balduzzi, Adriana, Barba, Pere, Bruno, Benedetto, Benjamin, Reuben, Carrabba, Matteo G., Chabannon, Christian, Ciceri, Fabio, Corradini, Paolo, Delgado, Julio, Di Blasi, Roberta, Greco, Raffaella, Houot, Roch, Iacoboni, Gloria, Jäger, Ulrich, Kersten, Marie José, Mielke, Stephan, Nagler, Arnon, Onida, Francesco, Peric, Zinaida, Roddie, Claire, Ruggeri, Annalisa, Sánchez-Guijo, Fermín, Sánchez-Ortega, Isabel, Schneidawind, Dominik, Schubert, Maria-Luisa, Snowden, John A., Thieblemont, Catherine, Topp, Max, Zinzani, Pier Luigi, Gribben, John G., Bonini, Chiara, Sureda, Anna, Yakoub-Agha, Ibrahim

Volltext

AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma von Leonard, John P, Trneny, Marek, Izutsu, Koji, Fowler, Nathan H, Hong, Xiaonan, Zhu, Jun, Zhang, Huilai, Offner, Fritz, Scheliga, Adriana, Nowakowski, Grzegorz S, Pinto, Antonio, Re, Francesca, Fogliatto, Laura Maria, Scheinberg, Phillip, Flinn, Ian W, Moreira, Claudia, Cabeçadas, José, Liu, David, Kalambakas, Stacey, Fustier, Pierre, Wu, Chengqing, Gribben, John G

Volltext

Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint... von Hayden, P.J., Roddie, C., Bader, P., Basak, G.W., Bonig, H., Bonini, C., Chabannon, C., Ciceri, F., Corbacioglu, S., Ellard, R., Sanchez-Guijo, F., Jäger, U., Hildebrandt, M., Hudecek, M., Kersten, M.J., Köhl, U., Kuball, J., Mielke, S., Mohty, M., Murray, J., Nagler, A., Rees, J., Rioufol, C., Saccardi, R., Snowden, J.A., Styczynski, J., Subklewe, M., Thieblemont, C., Topp, M., Ispizua, Á.U., Chen, D., Vrhovac, R., Gribben, J.G., Kröger, N., Einsele, H., Yakoub-Agha, I.

Volltext

First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE... von Moreno, Carol, Greil, Richard, Demirkan, Fatih, Tedeschi, Alessandra, Anz, Bertrand, Larratt, Loree, Simkovic, Martin, Novak, Jan, Strugov, Vladimir, Gill, Devinder, Gribben, John G, Kwei, Kevin, Dai, Sandra, Hsu, Emily, Dean, James P, Flinn, Ian W

Volltext

The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: Insight into disease biology and new targeted therapies von Burger, Jan A, Gribben, John G

Volltext

Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice von Gribben, John G., Bosch, Francesc, Cymbalista, Florence, Geisler, Christian H., Ghia, Paolo, Hillmen, Peter, Moreno, Carol, Stilgenbauer, Stephan

Volltext

The Wesley House Centenary Prayers von Gribben, Robert

Volltext

Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo von Hanna, B S, McClanahan, F, Yazdanparast, H, Zaborsky, N, Kalter, V, Rößner, P M, Benner, A, Dürr, C, Egle, A, Gribben, J G, Lichter, P, Seiffert, M

Volltext

Umbralisib and ublituximab: an upcoming regimen for chronic lymphocytic leukemia von Gribben, John

Volltext